DEA to reclassify marijuana: How this revolutionary shift impacts you - MDLinx

Summary

The article discusses the DEA's plan to reclassify cannabis from Schedule I to Schedule III, recognizing its medicinal value and lowering its potential for abuse, a move supported by Jon Gettman's efforts and tied to drug control laws. This change, still needing OMB approval, could enhance access to medical cannabis and stimulate further research.